CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 96 enrolled
Drug / intervention
Gabapentin +1 moredrug
Likely dose
Gabapentin 600mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02725710
NCT02725710Phase 2Completed
CompareCT.gov

Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration: a Randomized Controlled Trial

Duke University·interventional·Posted Apr 1, 2016·Updated Jul 2, 2019

In Brief

A Phase 2 clinical trial evaluating Gabapentin and Placebo for Other Abortion and Spontaneous Abortion. Completed, enrolled 96 participants across 1 site.

Detailed Summary

This is a randomized controlled double-blind placebo-controlled trial evaluating the impact of gabapentin given preoperatively on perioperative pain scores for women receiving uterine aspiration between 6 and 14+6 weeks gestation. This study will be a trial included in a prospective meta-analysis evaluating the use of gabapentin on perioperative pain in the abortion setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOther Abortion, Spontaneous Abortion
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 1, 2016
Enrollment StartAug 1, 2016
Primary CompletionJun 13, 2018
Study CompletionJun 14, 2018
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 10.3 years ago

Interventions

Gabapentindrug

600mg Gabapentin administered orally 1-2 hours prior to procedure

Placebodrug

Identical looking pill to the 600mg Gabapentin pill administered orally 1-2 hours prior to procedure